Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Immuron Limited ( (AU:IMC) ) is now available.
Immuron Limited has issued 877,440 ordinary shares without disclosure under Part 6D.2 of the Corporations Act, as per the notice given under section 708A(5)(e). The company confirms compliance with relevant provisions of the Corporations Act and states that there is no excluded information required to be disclosed. This issuance could potentially impact Immuron’s financial structure and investor relations by increasing the number of shares available in the market.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases. The company is listed on the Australian Securities Exchange (ASX) and NASDAQ, indicating its international market presence.
Average Trading Volume: 78,544
Technical Sentiment Signal: Sell
Current Market Cap: A$14.97M
See more insights into IMC stock on TipRanks’ Stock Analysis page.